Mineralocorticoid receptor mRNA expression is increased in human hippocampus following brief cerebral ischaemia

Neuropathology and Applied Neurobiology

Volumn 35, Issue 2, 2009, Pages 156-164

  Lai, M ^a   Bae, S E ^a   Bell, J E ^b   Seckl, J R ^a   MacLeod, M R ^a,b  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Cerebral ischaemia; Mineralocorticoid receptor; Neuroprotection

Indexed keywords

COMPLEMENTARY DNA; GLUCOCORTICOID RECEPTOR; MESSENGER RNA; MINERALOCORTICOID RECEPTOR; PROTEIN BAX; PROTEIN BCL 2;

ADULT; AGED; ARTICLE; BRAIN ISCHEMIA; CELL SURVIVAL; CLINICAL ARTICLE; DISEASE SEVERITY; FEMALE; GENE EXPRESSION; GENE OVEREXPRESSION; HEART ARREST; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; MALE; NERVE CELL; PRIORITY JOURNAL; RESUSCITATION; STROKE;

ADULT; AGED; BCL-2-ASSOCIATED X PROTEIN; BRAIN ISCHEMIA; FEMALE; HEART ARREST; HIPPOCAMPUS; HUMANS; IN SITU HYBRIDIZATION; MALE; MIDDLE AGED; PHOTOMICROGRAPHY; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTORS, MINERALOCORTICOID; RNA, MESSENGER; UP-REGULATION;

EID: 61849156197     PISSN: 03051846     EISSN: 13652990     Source Type: Journal    
DOI: 10.1111/j.1365-2990.2008.00980.x     Document Type: Article

References (23)

1. Reul J, de Kloet E. Two receptor systems for corticosterone in rat brain: microdistribution and differential occupation. Endocrinology 1985 117 : 2505 11
2. Evans R, Arriza J. A molecular framework for the actions of glucocorticoid hormones in the nervous system. Neuron 1989 2 : 1105 12
3. McCullers D, Herman J. Mineralocorticoid receptors regulate Bcl-2 and p53 mRNA expression in hippocampus. Neuroreport 1998 9 : 3085 9
4. Nair S, Werkman T, Craig J, Finnel R, Joels M, Eberwine J. Corticosteroid regulation of ion channel conductances and mRNA levels in individual hippocampal CA1 neurons. J Neurosci 1998 18 : 2685 96
5. Almeida O, Conde G, Crochemore C, Demeneix B, Fischer D, Hassan A, Meyer M, Holsboer F, Michaelidis T. Subtle shifts in the ratio between pro- and anti-apoptotic molecules after activation of corticosteroid receptors decide neuronal fate. FASEB J 2000 14 : 779 90
6. Woolley C, Gould E, Sakai R, Spencer R, McEwen B. Effect of aldosterone and RU28362 treatment on adrenalectomy induced cell death in the dentate gyrus of the adult brain. Brain Res 1991 554 : 312 15
7. Macleod M, Johansson I, Soderstrom I, Lai M, Gido G, Wieloch T, Seckl J, Olsson T. Mineralocorticoid receptor expression and increased survival following neuronal injury. Eur J Neurosci 2003 17 : 1549 55
8. Lai M, Seckl J, Macleod M. Overexpression of the mineralocorticoid receptor protects against injury in PC12 cells. Mol Brain Res 2005 135 : 276 9
9. Lai M, Horsburgh K, Bae S, Carter R, Stenvers D, Fowler J, Yau J, Gomez-Sanchez C, Holmes M, Kenyon C, Seckl J, Macleod M. Forebrain mineralocorticoid receptor overexpression enhances memory, reduces anxiety and attenuates neuronal loss in cerebral ischaemia. Eur J Neurosci 2007 25 : 1832 42
10. O'Collins V, Macleod M, Donna G, Horky L, Van der Worp B, Howells D. 1,026 experimental treatments in acute stroke. Ann Neurol 2006 59 : 467 77
11. Perel P, Roberts I, Sena E, Wheble P, Briscoe C, Sandercock P, Macleod M, Mignini L, Jayaram P, Khan S. Comparison of treatment effects between animal experiments and clinical trials: systematic review. BMJ 2007 334 : 197
12. Sena E, Van der Worp B, Howells D, Macleod M. How can we improve the pre-clinical development of drugs for stroke? Trends Neurosci 2007 30 : 433 39
13. Dirnagl U. Bench to bedside, the quest for quality in experimental stroke research. J Cereb Blood Flow Metab 2006 26 : 1465 78
14. Seckl J, Dickson K, Yates C, Fink G. Distribution of glucocorticoid and mineralocorticoid receptor messenger RNA expression in human post-mortem hippocampus. Brain Res 1991 561 : 332 7
15. Cervos-Navarro J, Diemer N. Selective vulnerability in brain hypoxia. Crit Rev Neurobiol 1991 6 : 149 82
16. Walton M, Connor B, Lawlor P, Young D, Sirimanne E, Gluckman P, Cole G, Dragunow M. Neuronal death and survival in two models of hypoxic-ischaemic brain damage. Brain Res Rev 1999 29 : 137 68
17. Van Eekelan J, Bohn M, de Kloet E. Postnatal ontogeny of mineralocorticoid and glucocorticoid receptor gene expression in regions of the rat tel- and di-encephalon. Dev Brain Res 1991 61 : 33 43
18. Bohn M, Dean D, Hussain S, Guiliano R. Development of mRNAs for glucocorticoid and mineralocorticoid receptor in rat hippocampus. Dev Brain Res 1994 77 : 157 62
19. Rigsby C, Burch A, Ogbi S, Pollock D, Dorrance A. Intact female stroke-prone hypertensive rats lack responsiveness to mineralocorticoid receptor antagonists. Am J Physiol Regul Integr Comp Physiol 2007 294 : R1754 63
20. Seckl J, Fink G. Antidepressants increase glucocorticoid and mineralocorticoid receptor mRNA expression in rat hippocampus in vivo. Neuroendocrinology 1992 55 : 621 6
21. Rothwell P, Giles M, Flossmann E, Lovelock C, Redgrave J, Warlow C, Mehta Z. A simple score (ABCD) to identify individuals at high early risk of stroke after transient ischaemic attack. Lancet 2005 366 : 29 36
22. Dorrance A, Osborn H, Grekin R, Webb R. Spironolactone reduces cerebral infarct size and EGF receptor mRNA in stroke prone rats. Am J Physiol Regul Integr Comp Physiol 2001 281 : R944 50
23. Pitt B, Remme W, Zannad F, Neaton J, Martinez F, Roniker D, Bittman R, Hurley D, Kleiman J, Gatlin M. Eplerenone post-acute myocardial infarction heart failure efficacy and survival study investigations. N Engl J Med 2002 348 : 1309 21